SCHEMBL1114486

SCHEMBL1114486

C[C@@H](C(=O)O)N(F)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.39
MLYCD O95822 1/20 0.39
KCNH2 Q12809 2/20 0.39
PGR P06401 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
HTR2A P28223 1/20 0.39
HRH1 P35367 1/20 0.39
PTGS2 P35354 1/20 0.38
CYP2D6 P10635 1/20 0.37
SRC P12931 1/20 0.37
GRIN2D O15399 2/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2A Q12879 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23630588 1.00 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2LMNATP53NPSR1
SCHEMBL30660130 0.84 ALOX5 (0.42) ALDH1A1SMN1; SMN2LMNATP53NPSR1
SCHEMBL2011663 0.81 HTT (0.42) ALDH1A1LMNATSHRCYP2B6CYP3A4
SCHEMBL2011662 0.81 HTT (0.42) ALDH1A1LMNATSHRCYP2B6CYP3A4
SCHEMBL157605 0.78 PTGS2 (0.45) ALDH1A1SMN1; SMN2LMNATP53NPSR1
SCHEMBL93387 0.78 PTGS2 (0.45) ALDH1A1SMN1; SMN2LMNATP53NPSR1
SCHEMBL502831 0.78 PTGS2 (0.45) ALDH1A1SMN1; SMN2LMNATP53NPSR1
SCHEMBL14463144 0.78 NPSR1 (0.44) ALDH1A1SMN1; SMN2LMNATP53NPSR1
SCHEMBL4387215 0.77 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2LMNATP53NPSR1
SCHEMBL755703 0.77 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2LMNATP53NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2011518179-A 2011-06-23 JP claimed
EP-2279200-A1 BIOLOGICALLY ACTIVE PEPTIDES Baxter International Inc. (US) 2011-02-02 EP claimed
WO-2009137256-A1 BIOLOGICALLY ACTIVE PEPTIDES BAXTER INTERNATIONAL INC. (US) 2009-11-12 WO claimed
EP-0728147-B1 RECEPTOR SPECIFIC ATRIAL NATRIURETIC PEPTIDES GENENTECH INC (US) 2003-02-12 EP claimed
US-5665704-A VASODILATORS, HYPOTENSIVE AGENTS; METABOLIC STABILITY GENENTECH, INC. (US) 1997-09-09 US claimed
CN-1112125-A Acyloxyhexanoic acid derivatives CIBA GEIGY AG (CH) 1995-11-22 CN claimed
JP-3160985-A None JP disclosed
EP-4358989-A2 BICYCLIC PEPTIDYL PAN-RAS INHIBITORS Ohio State Innovation Foundation (US) 2024-05-01 EP disclosed
WO-2022271810-A2 BICYCLIC PEPTIDYL PAN-RAS INHIBITORS OHIO STATE INNOVATION FOUNDATION (US) 2022-12-29 WO disclosed
EP-3849592-A1 MODIFIED IFNL3 POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCING MOIETY AND THEIR USES Exalt Therapeutics, LLC (US) 2021-07-21 EP disclosed
WO-2020041636-A1 MODIFIED IFNL3 POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCING MOIETY AND THEIR USES EXALT THERAPEUTICS, LLC (US) 2020-02-27 WO disclosed
EP-3145524-A2 SYNTHESIS OF BETA-ARRESTIN EFFECTORS Trevena, Inc. (US) 2017-03-29 EP disclosed
WO-2015179349-A2 SYNTHESIS OF BETA-ARRESTIN EFFECTORS TREVENA, INC. (US) 2015-11-26 WO disclosed
WO-2009137256-A1 BIOLOGICALLY ACTIVE PEPTIDES BAXTER INTERNATIONAL INC. (US) 2009-11-12 WO disclosed
EP-2104497-A2 UREA AND SULFAMIDE DERIVATIVES AS TAFIA INHIBITORS Sanofi-Aventis (FR) 2009-09-30 EP disclosed
WO-2009100255-A2 MODIFIED LEPTIN POLYPEPTIDES AND THEIR USES AMBRX, INC. (US) 2009-08-13 WO disclosed
WO-2008067909-A2 UREA AND SULFAMIDE DERIVATIVES AS TAFIA INHIBITORS SANOFI-AVENTIS (FR) 2008-06-12 WO disclosed
CN-1112125-A Acyloxyhexanoic acid derivatives CIBA GEIGY AG (CH) 1995-11-22 CN disclosed
JP-H03160985-A NOVEL VARIANT AND PREPARATION OF SOY SAUCE USING THEREOF KIKKOMAN CORP 1991-07-10 JP disclosed
EP-0331404-A2 Method for producing tropane alkaloid SEITAIKINOU RIYOU KAGAKUHIN SHINSEIZOUGIJUTSU KENKYU KUMIAI (JP) 1989-09-06 EP disclosed